Copyright
©The Author(s) 2022.
World J Clin Cases. Apr 6, 2022; 10(10): 3027-3034
Published online Apr 6, 2022. doi: 10.12998/wjcc.v10.i10.3027
Published online Apr 6, 2022. doi: 10.12998/wjcc.v10.i10.3027
Group | MCP-1 (pg/mL) | t | P value | GSH-Px (pg/mL) | t | P value | ||
Pre-operation | Post-operation | Pre-operation | Post-operation | |||||
Experimental group (n = 49) | 146.23 ± 10.05 | 215.25 ± 10.11 | 34.229 | < 0.001 | 1939.65 ± 10.14 | 1823.21 ± 10.15 | 55.053 | < 0.001 |
Control group (n = 47) | 145.61 ± 10.21 | 554.41 ± 10.23 | 205.944 | < 0.001 | 1941.54 ± 10.09 | 1642.17 ± 10.57 | 144.328 | < 0.001 |
t | 0.129 | 163.359 | - | - | 0.915 | 85.602 | - | - |
P value | 0.898 | < 0.001 | - | - | 0.362 | < 0.001 | - | - |
- Citation: Du D, Qiao Q, Guan Z, Gao YF, Wang Q. Combined sevoflurane-dexmedetomidine and nerve blockade on post-surgical serum oxidative stress biomarker levels in thyroid cancer patients. World J Clin Cases 2022; 10(10): 3027-3034
- URL: https://www.wjgnet.com/2307-8960/full/v10/i10/3027.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i10.3027